Skip to main content

Table 3 Results of semi-quantitative RT-PCR analysis

From: Thermochemotherapy effect of nanosized As2O3/Fe3O4complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9

  relative gray value (gene/β-actin), ( ± S)
Gene P 1 2 3 4 5 6
CD44v6 0.386 ± 0.049 0.396 ± 0.052 0.438 ± 0.115 0.210 ± 0.075(1) 0.244 ± 0.120(1) 0.142 ± 0.064(1)(2) 0.117 ± 0.030(1)(3)
VEGF-C 0.605 ± 0.166 0.514 ± 0.083 0.398 ± 0.079(1) 0.305 ± 0.132(1)(2) 0.344 ± 0.038(1) 0.095 ± 0.016(1)(3) 0.150 ± 0.036(1)
MMP-9 0.966 ± 0.205 1.053 ± 0.222 0.997 ± 0.093 0.461 ± 0.170(1) 0.466 ± 0.121(1) 0.244 ± 0.107(1)(2) 0.220 ± 0.098(1)(3)
  1. CD44v6: (1) p < 0.05 vs. P, (2) p < 0.05 vs. 3, (3) p < 0.05 vs. 4; VEGF-C: (1) p < 0.05 vs. P, (2) p < 0.05 vs. 2 and 4, (3) p < 0.05 vs. 6; MMP-9: (1) p < 0.05 vs. P, (2) p < 0.05 vs. 3, (3) p < 0.05 vs. 4.
  2. P, positive control (untreated HeLa cells); 1, Fe3O4 without MFH; 2, Fe3O4 plus MFH; 3, nanosized As2O3 (5 μM)/Fe3O4 plus MFH; 4, 5 μM As2O3; 5, nanosized As2O3 (10 μM)/Fe3O4 plus MFH group; 6, 10 μM As2O3.